BMY

Bristol Myers Squibb Stock Analysis

AI Rating

Great
  • Quality9/10
  • Growth↑ 9/10
  • Momentum↑ 7/10
Bristol Myers Squibb sales and earnings growth
BMY Growth
Great
  • Revenue Y/Y↓ -0.22%
  • EPS Y/Y↑ 178.68%
  • FCF Y/Y↓ -7.87%
Bristol Myers Squibb gross and profit margin trends
BMY Profitability
Good
  • Gross margin ↑ 71.10%
  • EPS margin↑ 14.60%
  • ROIC↑ 15.30%
Bristol Myers Squibb recent dividend growth
BMY Dividends
  • Dividend yield 4.11%
  • Growth 3Y↑ 4.29%
  • Payout ratio↑ 71%
Bristol Myers Squibb net debt vs free cash flow
BMY Risk
Fair
  • Debt / Equity↑ 2.4
  • Debt / FCF↓ 2.7
  • Interest coverage↓ NA

Bristol Myers Squibb stock is less volatile than the overall market, so it's low risk. We give it a Fair risk rating.

More Drug Manufacturers - General stocks ↗